The Study of 3D Printing-Assisted Electrospinning Technology in Producing Tissue Regeneration Polymer-Fibroin Scaffold for Ureter Repair

Hu, Han-Yen; Wu, Ching-Tang; Huang, Chengshuo; Bai, Meng–Yi; Yü, Dah‐Shyong

doi:10.5152/tud.2022.21217

Cited by 2 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We must mention the other biocompatible materials reported in different studies in the last decade that have yet to be adapted for VPP techniques but have great potential due to their chemical properties and biocompatibility. Some of these materials are feldspathic ceramic [154], poly(L-lactide) (PLLA) [155], PEG-DMAP [156], chitosan Bioink [157], α,ω-polytetrahydrofuranether-diacrylate (PTHF-DA) [158], trimethylolpropane triacrylate (TMPTMA) [159], nanocrystalline cellulose [160], nanofibrous silk fibroin [161], and zwitterionic hydrogels (Z-gels) [162]. All the biomaterials above show potential for use in 3D-printed tissue engineering builds, and the methods of adapting and implementing their use in the medical field are still under development.…”

Section: Conclusion and Future Perspectivesmentioning

confidence: 99%

Biomaterials Adapted to Vat Photopolymerization in 3D Printing: Characteristics and Medical Applications

Timofticiuc,

Călinescu,

Iftime

et al. 2023

JFB

View full text Add to dashboard Cite

Along with the rapid and extensive advancements in the 3D printing field, a diverse range of uses for 3D printing have appeared in the spectrum of medical applications. Vat photopolymerization (VPP) stands out as one of the most extensively researched methods of 3D printing, with its main advantages being a high printing speed and the ability to produce high-resolution structures. A major challenge in using VPP 3D-printed materials in medicine is the general incompatibility of standard VPP resin mixtures with the requirements of biocompatibility and biofunctionality. Instead of developing completely new materials, an alternate approach to solving this problem involves adapting existing biomaterials. These materials are incompatible with VPP 3D printing in their pure form but can be adapted to the VPP chemistry and general process through the use of innovative mixtures and the addition of specific pre- and post-printing steps. This review’s primary objective is to highlight biofunctional and biocompatible materials that have been adapted to VPP. We present and compare the suitability of these adapted materials to different medical applications and propose other biomaterials that could be further adapted to the VPP 3D printing process in order to fulfill patient-specific medical requirements.

show abstract